Please ensure Javascript is enabled for purposes of website accessibility

Sackler family

Members of the bankruptcy bar have watched, debated and questioned the results of the U.S. Supreme Court’s recent 5-4 ruling that upended an agreement related to the bankruptcy proceedings of Purdue Pharma, maker of OxyContin. (Depositphotos.com)
Sep 18, 2024

Ruling sparks interest, debate among bankruptcy bar

The U.S. Supreme Court's decision in the Purdue Pharma bankruptcy has led to diverse reactions from lawyers in that field, highlighting uncertainties in third-party liability releases and potential impacts on bankruptcy practices, particularly in mass tort cases.

In a 5-4 vote Thursday, the U.S. Supreme Court rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from lawsuits. (Associated Press file)
Jun 28, 2024

SCOTUS rejects nationwide Purdue Pharma opioid settlement

WASHINGTON — The Supreme Court on Thursday rejected a nationwide settlement with OxyContin maker Purdue Pharma that would have shielded members of the Sackler family who own the company from […]

Cases awaiting decisions this term from the U.S. Supreme Court range from presidential immunity involving former President Donald Trump to abortion to homelessness. (Associated Press file)
Jun 21, 2024

SCOTUS has much to do, little time left to do it

WASHINGTON — The U.S. Supreme Court is headed into its final few weeks with about a third of the cases heard this year still undecided, including ones that could reshape […]

The Texas two-step bankruptcy defense might be threatened by a small-but-important phrase is a recent U.S. Supreme Court opinion. (Depositphotos.com)
Jun 13, 2024

Attorney: Phrase in SCOTUS opinion suggests end for ‘Texas two-step’

By Kris Olson It may have been only three words in a U.S. Supreme Court decision. But plaintiffs’ attorney Michael C. Shepard of Boston hopes they portend that the last […]


Top Legal News

See All Top Legal News

Commentary

See All Commentary